NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Shandong Jincheng Pharmaceutical Group Co. Ltd (SHE: 300233)
300233 Technical Analysis
1.5
As on 12th Mar 2025 300233 STOCK Price closed @ 17.28 and we RECOMMEND Buy for LONG-TERM with Stoploss of 16.27 & Sell for SHORT-TERM with Stoploss of 18.17 we also expect STOCK to react on Following IMPORTANT LEVELS. |
300233STOCK Price
Open | 15.45 | Change | Price | % |
High | 17.28 | 1 Day | 2.88 | 20.00 |
Low | 15.40 | 1 Week | 4.22 | 32.31 |
Close | 17.28 | 1 Month | 4.33 | 33.44 |
Volume | 83348287 | 1 Year | -0.89 | -4.90 |
52 Week High 19.54 | 52 Week Low 10.73 |
SHE China Most Active Stocks
002195 | 6.77 | -2.87% |
002426 | 3.75 | -3.10% |
002131 | 4.30 | -0.23% |
300296 | 7.94 | -1.37% |
000903 | 4.40 | -1.35% |
300059 | 23.61 | 0.98% |
002183 | 5.73 | 0.17% |
000592 | 3.02 | -5.03% |
300459 | 6.80 | 1.04% |
300058 | 10.25 | 0.10% |
SHE China Top Gainers Stocks
SHE China Top Losers Stocks
300233 Daily Charts |
300233 Intraday Charts |
Whats New @ Bazaartrend |
300233 Free Analysis |
|
300233 Important Levels Intraday
RESISTANCE | 20.90 |
RESISTANCE | 19.74 |
RESISTANCE | 19.02 |
RESISTANCE | 18.30 |
SUPPORT | 16.26 |
SUPPORT | 15.54 |
SUPPORT | 14.82 |
SUPPORT | 13.66 |
300233 Forecast March 2025
4th UP Forecast | 25.03 |
3rd UP Forecast | 22.54 |
2nd UP Forecast | 21.01 |
1st UP Forecast | 19.47 |
1st DOWN Forecast | 15.09 |
2nd DOWN Forecast | 13.55 |
3rd DOWN Forecast | 12.02 |
4th DOWN Forecast | 9.53 |
300233 Weekly Forecast
4th UP Forecast | 19.00 |
3rd UP Forecast | 18.45 |
2nd UP Forecast | 18.11 |
1st UP Forecast | 17.77 |
1st DOWN Forecast | 16.79 |
2nd DOWN Forecast | 16.45 |
3rd DOWN Forecast | 16.11 |
4th DOWN Forecast | 15.56 |
300233 Forecast2025
4th UP Forecast | 36.26 |
3rd UP Forecast | 30.17 |
2nd UP Forecast | 26.41 |
1st UP Forecast | 22.65 |
1st DOWN Forecast | 11.91 |
2nd DOWN Forecast | 8.15 |
3rd DOWN Forecast | 4.39 |
4th DOWN Forecast | -1.7 |
Shandong Jincheng Pharmaceutical Group Co. Ltd ( SHE China Symbol : 300233 )
Sector : Basic Materials And Other Stocks in Same Sector
Sector : Basic Materials And Other Stocks in Same Sector
300233 Other Details
Segment | EQ | |
Market Capital | 11349604352.00 | |
Sector | Basic Materials | |
Industry | Chemicals | |
Offical website | > echo $website ; ?> |
300233 Address
![]() |
300233 Latest News
300233 Business Profile
Shandong Jincheng Pharmaceutical Group Co., Ltd, together with its subsidiaries, engages in the research and development, production, and sale of III, IV Cephalosporin intermediates in the People's Republic of China. It offers characteristic bulk drugs, pharmaceutical intermediates, and fine chemicals. The company was formerly known as Shandong Jincheng Pharmaceutical Co., Ltd. and changed its name to Shandong Jincheng Pharmaceutical Group Co., Ltd in May 2017. Shandong Jincheng Pharmaceutical Group Co., Ltd was founded in 2004 and is based in Zibo, the People's Republic of China. Address: No. 26, Kunxin Road, Zibo, China
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service